La bourse est fermée

Thermo Fisher Scientific Inc. (TMO)

NYSE - NYSE Prix différé. Devise en USD
Ajouter à la liste dynamique
581,21+1,84 (+0,32 %)
À la clôture : 04:00PM EDT
581,21 0,00 (0,00 %)
Échanges après Bourse : 05:35PM EDT

Thermo Fisher Scientific Inc.

168 Third Avenue
Waltham, MA 02451
United States
781 622 1000
https://www.thermofisher.com

Secteur(s)Healthcare
Secteur d’activitéDiagnostics & Research
Employés à temps plein122 000

Dirigeants clés

NomTitrePayerExercéAnnée de naissance
Mr. Marc N. CasperChairman, President & CEO8,01M52,48M1968
Mr. Stephen WilliamsonSenior VP & CFO2,95M12,14M1967
Mr. Michel LagardeExecutive VP & COO3,3M15,18M1975
Mr. Michael A. Boxer Esq.Senior VP & General Counsel1,76M2,9M1962
Mr. Gianluca PettitiExecutive Vice President2,11M1,82M1979
Mr. Joseph R. HolmesVP & Chief Accounting OfficerS.O.S.O.1980
Mr. Ryan J. SnyderSenior VP & Chief Information OfficerS.O.S.O.S.O.
Dr. Karen E. Nelson Ph.D.Chief Scientific OfficerS.O.S.O.S.O.
Mr. Rafael TejadaVice President of Investor RelationsS.O.S.O.S.O.
Ms. Sandy B. PoundVP & Chief Communications OfficerS.O.S.O.S.O.
Les montants ont été établis en date du 31 décembre 2022 et les valeurs de compensation concernent le dernier exercice fiscal clos à cette date. Le terme « rémunération » désigne le salaire, les bonus, etc. Le terme « exercé » est utilisé pour la valeur des options exercées au cours de l’exercice fiscal. Devise exprimée en USD.

Description

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, protein detection assays, and instruments; immunodiagnostics develops, manufactures and markets complete bloodtest systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. It offers products and services through a direct sales force, customer-service professionals, electronic commerce, and third-party distributors under Thermo Scientific; Applied Biosystems; Invitrogen; Fisher Scientific; Unity Lab Services; and Patheon and PPD. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.

Gouvernance d’entreprise

L’ISS Governance QualityScore de Thermo Fisher Scientific Inc. en date du 1 mars 2024 est 5. Les scores principaux sont Audit : 4; Société : 8; Droits des actionnaires : 4; Compensation : 6.

Résultats de gouvernance d’entreprise offerts par Institutional Shareholder Services (ISS). Les résultats indiquent un rang décile par rapport à l’indice ou à la région. Un résultat décile de 1 indique un risque de gouvernance faible, tandis que 10 indique un risque de gouvernance élevé.